Reasons why Oncotarget remains one of the Most Reliable Source of Scientific News

Oncotarget is a peer-reviewed journal that is released on a weekly basis covering various fields of oncology. The journal is publication by Impact Journal through its chief editors Mikhail Blagosklonny and Andrei V. Gudkov.

To most scholars, receiving full updates on different scientific developments may pose significant problems since they are mostly concerned with the legitimacy of the updates and the accuracy of the information. With Oncotarget journal taking a leading role, however, many scholars are able to rest easy confident that they will receive timely and credible updates. Learn more about Oncotarget at Research Gate.

The journal provides readers with the latest news on various fields in science and medicine that could have otherwise been buried in inaccessible newsletters and weekly magazines. It makes it easy for the researchers to keep up with the recent news that that may not have been available if the platform is not part of the university college subscription.

There are different ways that a researcher or science readers could keep updated with the latest information. The most practical and effective way is through subscribing to a reliable news channels run by online publishers in the field of your interest. Oncotarget is the most recommended online resource for researchers and readers interested in latest news in medicine and science.

Oncotarget focuses on spreading news on oncology. This is the main subject of the online journal but they also have other target areas of medicine such as cardiology, cell biology, pharmacology, and microbiology, among other fields. Therefore, Oncotarget is a multidisciplinary journal that offers free access to anyone who is interested in finding updates on oncology news and other fields of science and medicine. The peer-reviewed journal is published on a weekly basis making it timely and trustworthy. There is a lot of information in the journal on the developing research regarding cancer, its management, treatment, and associated therapies. Check Oncotarget journal at scimagojr.com

Oncotarget was rated 5.008-impact factor in 2015-2016 winning many awards, which proves its efficiency in providing information and spreading news about development in oncology. It is among top oncology journals in the world making it a better option compared to many paid subscription newsletters.

Leave a Reply

Your email address will not be published. Required fields are marked *